Literature DB >> 12885985

Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS).

J W M Chan1, C K Ng, Y H Chan, T Y W Mok, S Lee, S Y Y Chu, W L Law, M P Lee, P C K Li.   

Abstract

BACKGROUND: Severe acute respiratory syndrome (SARS) was diagnosed in Hong Kong in over 1700 patients between March and early June 2003.
METHODS: 115 patients diagnosed with SARS were admitted to Queen Elizabeth Hospital, a large regional hospital in Hong Kong, from March 2003, of whom 100 were either discharged or were dead at 31 May. The patients were prospectively studied after admission to assess their short term outcomes and the risk factors associated with adverse outcomes, defined as death or the need for mechanical ventilation
RESULTS: At the time of writing 18 patients had died, with a crude mortality rate of 15.7% and a 21 day mortality of 10% (standard error 3%). Thirty nine patients (34%) were admitted to the intensive care unit, 30 of whom (26%) required mechanical ventilation. Multivariate analysis showed that age above 60 (hazards ratio (HR) 3.5, 95% CI 1.2 to 10.2; p=0.02), presence of diabetes mellitus or heart disease (HR 9.1, 95% CI 2.8 to 29.1; p<0.001), and the presence of other comorbid conditions (HR 5.2, 95% CI 1.4 to 19.7; p=0.01) were independently associated with mortality. However, only the presence of diabetes mellitus and/or cardiac disease (HR 7.3, 95% CI 3.1 to 17.4; p<0.001) was associated with adverse outcomes as a whole.
CONCLUSION: SARS is a new disease entity that carries significant morbidity and mortality. Specific clinical and laboratory parameters predicting unfavourable outcomes have been identified.

Entities:  

Mesh:

Year:  2003        PMID: 12885985      PMCID: PMC1746764          DOI: 10.1136/thorax.58.8.686

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  16 in total

1.  Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention.

Authors:  M S Niederman; L A Mandell; A Anzueto; J B Bass; W A Broughton; G D Campbell; N Dean; T File; M J Fine; P A Gross; F Martinez; T J Marrie; J F Plouffe; J Ramirez; G A Sarosi; A Torres; R Wilson; V L Yu
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  The use of corticosteroids in SARS.

Authors:  Yuji Oba
Journal:  N Engl J Med       Date:  2003-05-15       Impact factor: 91.245

3.  Ribavirin in the treatment of SARS: A new trick for an old drug?

Authors:  Gideon Koren; Susan King; Sandra Knowles; Elizabeth Phillips
Journal:  CMAJ       Date:  2003-05-13       Impact factor: 8.262

4.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

Authors:  Christian Drosten; Stephan Günther; Wolfgang Preiser; Sylvie van der Werf; Hans-Reinhard Brodt; Stephan Becker; Holger Rabenau; Marcus Panning; Larissa Kolesnikova; Ron A M Fouchier; Annemarie Berger; Ana-Maria Burguière; Jindrich Cinatl; Markus Eickmann; Nicolas Escriou; Klaus Grywna; Stefanie Kramme; Jean-Claude Manuguerra; Stefanie Müller; Volker Rickerts; Martin Stürmer; Simon Vieth; Hans-Dieter Klenk; Albert D M E Osterhaus; Herbert Schmitz; Hans Wilhelm Doerr
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

5.  A major outbreak of severe acute respiratory syndrome in Hong Kong.

Authors:  Nelson Lee; David Hui; Alan Wu; Paul Chan; Peter Cameron; Gavin M Joynt; Anil Ahuja; Man Yee Yung; C B Leung; K F To; S F Lui; C C Szeto; Sydney Chung; Joseph J Y Sung
Journal:  N Engl J Med       Date:  2003-04-07       Impact factor: 91.245

6.  A cluster of cases of severe acute respiratory syndrome in Hong Kong.

Authors:  Kenneth W Tsang; Pak L Ho; Gaik C Ooi; Wilson K Yee; Teresa Wang; Moira Chan-Yeung; Wah K Lam; Wing H Seto; Loretta Y Yam; Thomas M Cheung; Poon C Wong; Bing Lam; Mary S Ip; Jane Chan; Kwok Y Yuen; Kar N Lai
Journal:  N Engl J Med       Date:  2003-03-31       Impact factor: 91.245

7.  Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus.

Authors:  J B M van Woensel; W M C van Aalderen; W de Weerd; N J G Jansen; J P J van Gestel; D G Markhorst; A J van Vught; A P Bos; J L L Kimpen
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

8.  A novel coronavirus associated with severe acute respiratory syndrome.

Authors:  Thomas G Ksiazek; Dean Erdman; Cynthia S Goldsmith; Sherif R Zaki; Teresa Peret; Shannon Emery; Suxiang Tong; Carlo Urbani; James A Comer; Wilina Lim; Pierre E Rollin; Scott F Dowell; Ai-Ee Ling; Charles D Humphrey; Wun-Ju Shieh; Jeannette Guarner; Christopher D Paddock; Paul Rota; Barry Fields; Joseph DeRisi; Jyh-Yuan Yang; Nancy Cox; James M Hughes; James W LeDuc; William J Bellini; Larry J Anderson
Journal:  N Engl J Med       Date:  2003-04-10       Impact factor: 91.245

9.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

10.  Development of a standard treatment protocol for severe acute respiratory syndrome.

Authors:  Loletta K-Y So; Arthur C W Lau; Loretta Y C Yam; Thomas M T Cheung; Edwin Poon; Raymond W H Yung; K Y Yuen
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

View more
  161 in total

Review 1.  Severe acute respiratory syndrome (SARS): epidemiology and clinical features.

Authors:  D S C Hui; M C H Chan; A K Wu; P C Ng
Journal:  Postgrad Med J       Date:  2004-07       Impact factor: 2.401

2.  Small molecules targeting severe acute respiratory syndrome human coronavirus.

Authors:  Chung-Yi Wu; Jia-Tsrong Jan; Shiou-Hwa Ma; Chih-Jung Kuo; Hsueh-Fen Juan; Yih-Shyun E Cheng; Hsien-Hua Hsu; Hsuan-Cheng Huang; Douglass Wu; Ashraf Brik; Fu-Sen Liang; Rai-Shung Liu; Jim-Min Fang; Shui-Tein Chen; Po-Huang Liang; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-28       Impact factor: 11.205

3.  Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivors.

Authors:  C K Ng; J W M Chan; T L Kwan; T S To; Y H Chan; F Y Y Ng; T Y W Mok
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

4.  Hypertensive urgencies and emergencies: Misconceptions and pitfalls.

Authors:  Fabio Angeli; Gianpaolo Reboldi; Paolo Verdecchia
Journal:  Eur J Intern Med       Date:  2019-11-06       Impact factor: 4.487

Review 5.  The role of biomarkers in diagnosis of COVID-19 - A systematic review.

Authors:  Muhammed Kermali; Raveena Kaur Khalsa; Kiran Pillai; Zahra Ismail; Amer Harky
Journal:  Life Sci       Date:  2020-05-13       Impact factor: 5.037

6.  Methods for estimating the case fatality ratio for a novel, emerging infectious disease.

Authors:  A C Ghani; C A Donnelly; D R Cox; J T Griffin; C Fraser; T H Lam; L M Ho; W S Chan; R M Anderson; A J Hedley; G M Leung
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

7.  Severe acute respiratory syndrome: clinical and laboratory manifestations.

Authors:  Christopher W K Lam; Michael H M Chan; Chun K Wong
Journal:  Clin Biochem Rev       Date:  2004-05

8.  A correlation between the severity of lung lesions on radiographs and clinical findings in patients with severe acute respiratory syndrome.

Authors:  Yung-Liang Wan; Pei-Kwei Tsay; Yun-Chung Cheung; Ping-Cherng Chiang; Chun-Hua Wang; Ying-Huang Tsai; Han-Ping Kuo; Kuo-Chien Tsao; Tzou-Yien Lin
Journal:  Korean J Radiol       Date:  2007 Nov-Dec       Impact factor: 3.500

9.  Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection.

Authors:  Yan Wang; Jiangwei Yan; Yuling Shi; Ping Li; Chuanxuan Liu; Qingjun Ma; Ruifu Yang; Xiaoyi Wang; Lina Zhu; Xiao Yang; Cheng Cao
Journal:  BMC Infect Dis       Date:  2009-05-01       Impact factor: 3.090

10.  The SARS-CoV ferret model in an infection-challenge study.

Authors:  Yong-Kyu Chu; Georgia D Ali; Fuli Jia; Qianjun Li; David Kelvin; Ronald C Couch; Kevin S Harrod; Julie A Hutt; Cheryl Cameron; Susan R Weiss; Colleen B Jonsson
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.